An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles
Kojic acid (KA) as tyrosinase inhibitor shows insufficient skin penetration and several adverse events due topical administration. KA solid lipid nanoparticles (KA-SLNs) were prepared using high speed homogenisation followed by ultra-probe sonication method for improve its effectiveness.KA-SLNs was...
Main Authors: | Khadijeh Khezri, Majid Saeedi, Katayoun Morteza-Semnani, Jafar Akbari, Seyyed Sohrab Rostamkalaei |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2020.1770271 |
Similar Items
-
A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier
by: Khadijeh Khezri, et al.
Published: (2021-01-01) -
Review on the Use of Kojic Acid—A Skin-Lightening Ingredient
by: Vivey Phasha, et al.
Published: (2022-06-01) -
Targeting and Inhibiting Plasmodium berghei Growth in Balb/c Mice Using Kojic Acid-Solid Lipid Nanoparticles and Kojic Acid-Nanostructured Lipid Carriers
by: Mehdi Nateghpour*, et al.
Published: (2023-08-01) -
Hyperpigmentation in skin of colour: Therapeutical benefits of isobutylamido‐thiazolyl‐resorcinol (Thiamidol®), an effective tyrosinase inhibitor, in phototypes IV–VI
by: Barbara Schuster, et al.
Published: (2024-07-01) -
Optimization of the extraction process and molecular mechanism of inhibition on tyrosinase of kojic acid
by: FANG Jingjie, et al.
Published: (2024-01-01)